Table 2.
Principal laboratory and clinical parameters of the patient before and after TCZ treatment.
| Baseline | 4th month | 12th month | 24th month | 36th month | |
|---|---|---|---|---|---|
| PCR (mg/l) | 8.5 | 1 | 1 | 1 | 1 |
| VES (mm/1h) | 48 | 12 | 11 | 15 | 13 |
| DAS28 | 4.25 | 1.7 | 1.5 | 1.8 | 1.2 |
| SDAI | 27.85 | 4.1 | 3.3 | 3.2 | 2.9 |
| CDAI | 27 | 4 | 3.2 | 3.1 | 2.8 |
| HAQ | 2.125 | 1 | 0.75 | 0.75 | 0.75 |